Risultati per: FDA approva una pillola contro la depressione a effetto rapido

This Perspective discusses new FDA guidance for pulse oximeters that aims to reduce disparities in device performance related to skin pigment.

The US Food and Drug Administration (FDA) recently approved the rapid-acting human insulin analog insulin-aspart-szjj, marketed as Merilog, as a biosimilar to insulin aspart (Novolog).

This JAMA Insights discusses the recent FDA approval of obecabtagene autoleucel for adults with relapsed or refractory B-cell acute lymphoblastic leukemia and provides regulatory considerations.

So far, studies suggest modest benefits for acute postoperative pain, but many questions remain.

Semaglutide, marketed as Ozempic, recently became the first glucagon-like peptide 1 (GLP-1) receptor agonist approved by the US Food and Drug Administration (FDA) to reduce the risk of worsening kidney disease, kidney failure, and death due to cardiovascular disease in adults with type 2 diabetes (T2D) and chronic kidney disease (CKD), a common complication of T2D.

Test clinici la promuovono. L’esperto: ‘Mai come sostitutivo del medico’

Ok alla rimborsabilità negli stadi iniziali della malattia, può aumentare le guarigioni

Più comuni in femmine, a scapito di sostanze neuroprotettive

The US Food and Drug Administration (FDA) recently authorized the marketing of 20 ZYN nicotine pouch products, the first of their kind to receive such approval. The decision followed an extensive scientific review that concluded that the benefits of these cigarette alternatives outweighed the risks, in line with the public health standards set by the 2009 Family Smoking Prevention and Tobacco Control Act.

The respiratory syncytial virus (RSV) vaccines marketed as Abrysvo by Pfizer and Arexvy by GSK will now require a warning about the risk of Guillain-Barré syndrome (GBS), the US Food and Drug Administration (FDA) announced recently.

Collaborazione tra SISSA e Alifax sviluppa nuova tecnica

Collaborazione tra SISSA e Alifax sviluppa nuova tecnica

Gli esperti, ‘anche i medici responsabili, colmare il divario’

The US Food and Drug Administration (FDA) recently approved liraglutide to treat type 2 diabetes in combination with diet and exercise, which makes it the first generic version of Victoza and the second glucagon-like peptide-1 (GLP-1) receptor agonist authorized as a generic drug.

New England Journal of Medicine, Ahead of Print.

Grocery items marketed as “healthy” will soon need to meet a new US Food and Drug Administration (FDA) rule that now focuses on whole foods.